(Q38286201)

1 September 2017

1 reference

title

Risk-benefit analysis of antidepressant drug treatment in the elderly (English)

1 reference

1 September 2017

1

Cecilio Alamo

1 reference

1 September 2017

Francisco López-Muñoz

series ordinal

2

object named as

Francisco López-Muñoz

1 reference

1 September 2017

Pilar García-García

3

1 reference

1 September 2017

Silvia García-Ramos

series ordinal

4

1 reference

1 September 2017

publication date

1 December 2014

1 reference

Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society

1 September 2017

published in

1 reference

1 September 2017

volume

14

1 reference

1 September 2017

issue

4

1 reference

1 September 2017

page(s)

261-268

1 reference

Prevalence and treatment of diagnosed depression among elderly nursing home residents in Ohio

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Antidepressants for depressed elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

A practical approach to prescribing antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Recommendations for treating depression in community-based older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Use of antidepressants in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Pharmacokinetics and drug metabolism in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Monoamine oxidase inhibitors. A perspective on their use in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Long term effect of depression care management on mortality in older adults: follow-up of cluster randomized clinical trial in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Depression as a risk factor for non-suicide mortality in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Antidepressant use and risk of adverse outcomes in older people: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Association between antidepressant prescribing and suicide in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Antidepressants and risks of suicide and suicide attempts: a 27-year observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Antidepressant Utilization and Suicide in Europe: An Ecological Multi-National Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Antidepressants and falls in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

QT interval and antidepressant use: a cross sectional study of electronic health records

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Sertraline treatment of major depression in patients with acute MI or unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Selective serotonin reuptake inhibitors and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Risk of ischemic stroke associated with antidepressant drug use in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Venlafaxine and risk of upper gastrointestinal bleeding in elderly depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Antidepressant drug prescription and risk of abnormal bleeding: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Which medications to avoid in people at risk of delirium: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Delirium masquerading as depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Agomelatine: a new option for treatment of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Sexual side-effects of contemporary antidepressants: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Depression and osteoporosis: a research synthesis with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Relationship between use of antidepressants and risk of fractures: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

Antidepressants in elderly: metaregression of double-blind, randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12057

21 January 2018

Identifiers

DOI

10.1111/PSYG.12057

1 reference

1 September 2017

1 reference